Cochrane · intervention · CD007975

Topical treatments for HIV‐related oral ulcers

Kuteyi, T, Okwundu, CI · Cochrane Database of Systematic Reviews · 2012 · Cochrane Library

HIV/AIDSOral HealthOther oral health2 versionsAMSTAR 2: not assessed
Full textEvery question was extracted from the full review (methods and results), not only its Summary of Findings table.
Questions
20
current version
GRADE rated
0
No studies
20
Included studies
0
as reported
No studies 20 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Review question

ElementPlanned (methods)Found (results)
PopulationHIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcersInsufficient data
InterventionTopical corticosteroids; Topical thalidomide; Antiseptic mouth washes such as chlorhexidine; Any HAART regimen + any topical treatmentInsufficient data
ComparisonAnother topical agent; Placebo; HAART regimen aloneInsufficient data
OutcomesHealing of ulceration; Pain relief; Duration to heal oral ulcerations after initiation of treatment; Incidence and recurrence after healing of ulcers; Adverse effects of long‐term use of available topical agentsInsufficient data
Study designsRandomised controlled trialsInsufficient data
TimingNot specifiedInsufficient data

Search date: 2011-05. Databases: PUBMED; EMBASE; The Cochrane Central Register of Controlled Trials (CENTRAL); AEGIS; ClinicalTrials.gov

Questions and results

Show all 2 versions

Topical corticosteroids vs Another topical agent or placebo

Population: HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers
5 questions
OutcomeEffectEvidenceStatus / GRADE
Pain relief
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Adverse effects of long‐term use of available topical agents
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Duration to heal oral ulcerations after initiation of treatment
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Healing of ulceration
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Incidence and recurrence after healing of ulcers
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies

Topical thalidomide vs Another topical agent or placebo

Population: HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers
5 questions
OutcomeEffectEvidenceStatus / GRADE
Incidence and recurrence after healing of ulcers
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Pain relief
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Adverse effects of long‐term use of available topical agents
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Healing of ulceration
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Duration to heal oral ulcerations after initiation of treatment
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies

Antiseptic mouthwash (e.g. chlorhexidine) vs Another topical agent or placebo

Population: HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers
5 questions
OutcomeEffectEvidenceStatus / GRADE
Pain relief
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Incidence and recurrence after healing of ulcers
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Duration to heal oral ulcerations after initiation of treatment
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Healing of ulceration
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Adverse effects of long‐term use of available topical agents
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies

HAART regimen + topical treatment vs HAART regimen alone

Population: HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers
5 questions
OutcomeEffectEvidenceStatus / GRADE
Adverse effects of long‐term use of available topical agents
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Duration to heal oral ulcerations after initiation of treatment
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Healing of ulceration
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Pain relief
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Incidence and recurrence after healing of ulcers
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies